Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
ActivCell Group AG is a Swiss cold plasma medical technology company. The website is not centered on traditional SaaS or enterprise software, but on portable, wireless cold plasma therapy pens for medical professionals. Its product lineup covers both veterinary and human medicine: the EquCell pen is designed for equine practice, the PetCell pen for small-animal veterinary practice, and the ActivCell pen for wound and skin care in human medicine.
Based on the captured content, the core value lies in integrating modern cold plasma technology into a handheld, wireless pen device, making it convenient for use in routine consultations, stables, or small-animal clinics. The site highlights that the therapy can be used for multiple medical indications and may support faster, better healing outcomes. Supporting content includes explanations of the technology, mechanism of action, indications, reference cases, resources, literature, news, and webinars, with a clear focus on professional education and market development.
The pages do not disclose any plans, pricing, purchasing methods, trials, or payment information. There are also no visible SaaS elements such as subscriptions, account systems, team permissions, third-party integrations, APIs, or developer support. As a result, if evaluated from an enterprise software perspective, the available information is very limited; it is better understood as the official website for a medical device product rather than a software service platform.
One valuable piece of information is its regulatory progress: the ActivCell pen received CE certification under the European MDR on July 20, 2023. The device category is MDA, and it is intended for wound and skin care, indicating that the human-medicine product has achieved a clear regulatory milestone in Europe. However, the website also states that market entry is still in preparation, so commercial availability still needs to be confirmed.
The advantages are a clear product positioning, a portable wireless form factor suited to clinical and field veterinary scenarios, and the availability of multilingual and professional resources. The drawbacks are that commercial terms, service support, availability in China, after-sales arrangements, and clinical usage boundaries are not fully presented in the main content. It is suitable for veterinary clinics, equine practitioners, and human medical institutions evaluating cold plasma wound and skin care solutions.
The captured text does not provide information on access from China, payment methods, agents, or local registration, so access status can only be marked as unknown. If purchasing in China, buyers should focus on verifying medical device registration, import qualifications, local after-sales support, and payment channels. Alternatives should be compared separately under categories such as “cold plasma therapy devices” or “veterinary wound care devices.”
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on cosmetcell.ch official site.
cosmetcell.ch is an Switzerland Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach cosmetcell.ch directly.